Jesper van Breeschoten
Jesper van Breeschoten publishes mostly in Oncology, Molecular Biology and Economics and Econometrics, on topics such as Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways and Cancer Immunotherapy and Biomarkers.
- World rank
- #2,696,411 of 7,710,434 ranked researchers
- Rank in Netherlands
- #56,267 of 107,149
- Works
- 29
- Citations
- 396
- Citations per work
- 13.7
What does Jesper van Breeschoten research?
Jesper van Breeschoten's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (13%), Economics, Econometrics and Finance (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1964.0%
- Medicine1964.0%
- Life Sciences413.3%
- Everything else312.0%
- Social Sciences310.7%
- 1Oncology49% of their works
- 2Molecular Biology13% of their works
- 3Economics and Econometrics11% of their works
- 4Pulmonary and Respiratory Medicine8% of their works
- 5Public Health, Environmental and Occupational Health4% of their works
- 6Epidemiology3% of their works
Research topics
- Cutaneous Melanoma Detection and Management
- Melanoma and MAPK Pathways
- Cancer Immunotherapy and Biomarkers
- Health Systems, Economic Evaluations, Quality of Life
- COVID-19 and healthcare impacts
- Economic and Financial Impacts of Cancer
- Immunotherapy and Immune Responses
- Colorectal Cancer Treatments and Studies
Which keywords describe Jesper van Breeschoten's research?
The keywords of their largest research topics: Melanoma, Dermoscopy, Skin Cancer, BRAF gene, MAP Kinase, Immune Checkpoint Blockade, PD-1 and PD-L1 and Cost-effectiveness Analysis.
- Immunity
- Cetuximab
- Cost of Care
- COVID-19
- Cost-effectiveness Analysis
- Immune Checkpoint Blockade
- BRAF gene
- Dermoscopy
- Melanoma
- Skin Cancer
- MAP Kinase
- PD-1 and PD-L1
- Quality of Life
- Cancer
- Financial Toxicity
- Dendritic Cells
- KRAS Mutations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Melanoma262 topics
- Dermoscopy161 topic
- Skin Cancer161 topic
- BRAF gene101 topic
- MAP Kinase101 topic
- Immune Checkpoint Blockade71 topic
- PD-1 and PD-L171 topic
- Cost-effectiveness Analysis51 topic
- Quality of Life51 topic
- COVID-1941 topic
- Cancer41 topic
- Cost of Care31 topic
- Financial Toxicity31 topic
- Cetuximab21 topic
- Dendritic Cells21 topic
- Immunity21 topic
- KRAS Mutations21 topic
Where does Jesper van Breeschoten work?
Jesper van Breeschoten's main affiliation in the publication record is Dutch Institute for Clinical Auditing, Netherlands.
How many publications and citations does Jesper van Breeschoten have?
OpenAlex counts 29 works and 396 citations for Jesper van Breeschoten, an h-index of 10, ranking #2,696,411 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jesper van Breeschoten. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.